NVAC

Exhibitor

The Novo Nordisk Foundation Initiative for Vaccines and Immunity (NIVI), launched in December 2023, has a unique mission to harness airway immunity through innovative vaccine research and development to prevent airborne epidemics.  NIVI has two parts:

• NIVI Research Center: A cutting-edge research center anchored to the University of Copenhagen.
• NIVI Development: A company that focuses on translational sciences and advancing vaccine development.

NIVI Research Center conducts scientific research, while NIVI Development works to quickly turn that research into new vaccine candidates. NIVI Development accelerates clinical trials (phases 1 and 2) and ensures a smooth transition to partners for later stages of development.

By connecting science, innovation, clinical trials, regulatory processes, and product development, NIVI aims to streamline the journey from research to real-world vaccines.

website